Merck & Co Unusual Options Activity

Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 8 unusual trades.Delving into the details, we found 12% of trade

Benzinga01:18

Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients

On Thursday, Roche Holdings AG (OTC:RHHBY) said that the Phase 2/3 SKYSCRAPER-06 study of tiragolumab plus Tecentriq (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as first-line

BenzingaJul 5 20:09

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,300 Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 10 years by 1.82% on an annualized basis producing an average annual return of 12.66%. Currently, Regeneron Pharmaceut

BenzingaJul 4 23:30

Here's How Much $100 Invested In Sarepta Therapeutics 10 Years Ago Would Be Worth Today

Sarepta Therapeutics (NASDAQ:SRPT) has outperformed the market over the past 10 years by 8.61% on an annualized basis producing an average annual return of 19.45%. Currently, Sarepta Therapeutics has

BenzingaJul 4 22:30

List of cloud breakout stocks (Part 1) [Ichimoku Kinko Hyo Cloud Breakout Stock List]

List of high-flying stocks: Market Code Stock Name Closing Price Leading Span A Leading Span B TOPIX\t\t<1719> Ando Hazama\t 1195\t\t1145.75\t\t1194.5\n \t<1773> YTL\t\t\t 129\t\t123.75\t\t115.5\n \t<1941> Chuden Kogyo\t 3210\t\t3162.5\t\t3205.5\n \t<1961> Main Board

Fisco JapanJul 4 06:43

Top High Quality Stocks That Pay Dividends - UBS

Seeking AlphaJul 3 22:23